6-K
Foreign Interim / Material
Baird Medical Investment Holdings Ltd BDMD BDMDW
0001104659-25-118866
- Filed
- Dec 5, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 26.4M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 25.56M sh |
| Capex | Q2 2025 · Jun 30, 2025 | $44.61K |
| Capex | Q2 2025 · Jun 30, 2024 | $484.84K |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | −$3.19M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | −$3.96M |
| Long Term Debt | Q2 2025 · Jun 30, 2025 | $5.81M |
| Long Term Debt | Q2 2025 · Dec 31, 2024 | $3.44M |
| Short Term Debt | Q2 2025 · Jun 30, 2025 | $2.59M |
| Short Term Debt | Q2 2025 · Dec 31, 2024 | $867.77K |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $35.59M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $39.66M |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $35.47M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $34.62M |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $41.37M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $38.2M |
| Current Assets | Q2 2025 · Jun 30, 2025 | $60.75M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $61.42M |
| Total Assets | Q2 2025 · Jun 30, 2025 | $76.99M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $77.96M |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$0.43 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | $0.17 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$0.43 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | $0.17 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $8.68M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $3.21M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $7.18M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $2.03M |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$10.45M |
| Operating Income | Q2 2025 · Jun 30, 2024 | $5.09M |
| Gross Profit | Q2 2025 · Jun 30, 2025 | $6.54M |
| Gross Profit | Q2 2025 · Jun 30, 2024 | $11.49M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $1.42M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $1.65M |
| Revenue | Q2 2025 · Jun 30, 2025 | $7.96M |
| Revenue | Q2 2025 · Jun 30, 2024 | $13.14M |